We found that the circulating caspase-4 was significantly lower in chronic lymphocytic leukaemia (CLL, n = 12), non-Hodgkin lymphoma (NHL, n = 12) and multiple myeloma (MM, n = 12) (Figure 2B). Here, CASP4 is linked to plasma cell myeloma.